INmune Bio, Inc. to Present at the 32nd Annual ROTH Conference on March 17

search

newsroom latest news (container)

Recent News

Jun 30, 2025

INmune Bio, Inc. Announces Closing of Approximately $19 Million Registered Direct Offering Priced At...

Read More

Jun 30, 2025

INmune Bio Reports Key Findings from Phase 2 MINDFuL Trial of XPro™ in Early Alzheimer’s Disease

Read More

Jun 27, 2025

INmune Bio, Inc. Announces Approximately $19 Million Registered Direct Offering Priced At-the-Market...

Read More

This website uses cookies to facilitate the use of the website, improve its performance and security, and personalize the proposed content.